Détail de l'éditeur
Documents disponibles chez cet éditeur (434)
Chapitre
Nearly all European countries now frame their drug policy initiatives within an overall national drugs strategy or action plan. An in-depth analysis of drug policy in Europe in this Selected issue reveals a broadening of the scope of these drug [...]Rapport
This Manual is a joint production by the EMCDDA and the Prevention Standards Partnership, and presents and describes basic and expert level quality standards for drug prevention. The standards cover all aspects of drug prevention work, including[...]Rapport
The aim of this 'quick guide' is to make practical information on prevention quality standards available outside the European Union. A condensed version of EMCDDA Manual 7, it includes a description of the eight stages involved in the drug preve[...]Document multimédia
FRANÇAIS : La diversification de l'offre et de l'usage de drogues crée de nouvelles problématiques pour la politique en matière de drogue, de soins et de santé en Europe. [...] Ce rapport fournit la dernière vue d'ensemble existante de la situa[...]Rapport
In the last year, there has been decriminalisation of all drug use in Portugal, a Policy Note in Belgium to decriminalise cannabis possession, and the start of the process to downgrade the offence of cannabis possession in the UK. This brief rep[...]Rapport
This study aims to give a descriptive overview of the various legal mechanisms used to sanction this phenomenon - whether provisions exist in drug control laws or road traffic laws, the substances addressed, the status and levels of penalties, a[...]Rapport
FRANÇAIS : Ce bref rapport analyse les similitudes entre les mesures nationales dans le domaine du traitement de substitution avec des substances sous contrôle et les obligations posées par les Conventions Internationales. (Résumé d'auteur) [...]Rapport
When a new psychoactive substance appears on the market, legislators need to choose whether to bring it under control of the drug laws, and for public health reasons they may need to do so quickly. A comparative study of the systems and procedur[...]Rapport
This analysis describes and compares the different substances often referred to as "medicinal cannabis" and their methods of administration, as well as the various methods and levels of permission and control under international, EU and national[...]Rapport
This paper analyses primary studies that examine the consequences of drug law changes, and describes their approach and methodologies. They were categorised as changes to laws addressing illegal use and possession, changes in laws regulating leg[...]Document texte divers
This table, a working document, lists approximately 500 substances controlled by the EU Member States and Norway, and aims to provide an at-a-glance guide as to where and if the substance is controlled within each country's legal system. Its Exc[...]Rapport
All countries use legal or judicial means to grade the severity of the offence of drug possession and related actions. Frequently this is done by reference to the quantity of drugs involved in the offence, and some countries choose to indicate c[...]Rapport
As involvement with drugs rises amongst young people under the age of 18, this study looks at the various national laws across the EU and candidate countries that aim to address this issue. The study concentrates on legislation covering three as[...]Rapport
ENGLISH: This handbook has been developed with the primary purpose of providing specific reference material for the European Prevention Curriculum (EUPC) training courses. It also serves to provide a more general introduction to prevention scie[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; L. ROYUELA ; M. ROSA ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014This is a first common questionnaire on drug use among prisoners at European level. The questionnaire is the results of two years of work in the field of drugs and prison, which has included the agreement on a methodological framework or monitor[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; V. MRAVCIK ; K. GROHMANNOVA ; L. ROYUELA | Lisbon : OEDT / EMCDDA | Technical reports | 2017This is the final version of the questionnaire on drug use among prisoners at European level. The questionnaire is the results of several years of work in the field of drugs and prison, which has included the agreement on a methodological framew[...]Rapport
FRANÇAIS : Ce rapport fournit une analyse descriptive du contexte historique, du cadre opérationnel et du bilan des services permettant une consommation de drogue contrôlée. A partir d'une revue de la littérature, il vise à sensibiliser l'opin[...]Rapport
This paper explores the evidence base for services designed to meet the needs of people who experience homelessness and use drugs (PEHAD). Through a delimited analysis of existing systematic and rapid evidence reviews, it considers the key lesso[...]Rapport
OEDT = EMCDDA ; T. NÉFAU ; E. LEFRANÇOIS ; V. DETREZ ; T. SEYLER ; B. GUARITA ; ESCAPE Network | Lisbon : OEDT / EMCDDA | Technical reports | 2021This protocol documents a new approach that has been developed to monitor substances injected by people who inject drugs through analytically confirmed data at the local level: the analysis of residual content of used syringes. Used syringes con[...]Rapport
Article 5.1 of Council Decision 2005/387/JHA (hereinafter referred to as the 'Decision') stipulates that 'Where Europol and the EMCDDA, or the Council, acting by a majority of its members, consider that the information provided by the Member Sta[...]Rapport
This document summarises the main issues concerning evaluation in the field of drug policy. Aimed at those managing rather than undertaking drug policy evaluations, the guide acts as an introduction, providing links to the wider literature. Reco[...]Livre
M. NILSON ; G. BURKHART ; C. KROGER ; H. WINTER ; O. BAKER ; J. MOUNTENEY ; NEAMAN R. | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 1998FRANÇAIS : Cette monographie reprend les conclusions de la première conférence européenne sur l'évaluation de la prévention contre la drogue. La première partie est centrée sur l'histoire, les fondements et l'évaluation de la recherche en mati[...]Livre
M. NILSON ; A. KOKKEVI ; P. P. MERINO ; BLUM M. | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 1999FRANÇAIS : En raison de l'augmentation des problèmes liés à la drogue et des moyens financiers limités qui leur sont affectés, la nécessité de gérer efficacement les coûts des traitements et d'obtenir les résultats les meilleurs au moindre coû[...]Livre
Commission européenne = European Commission ; NEAMAN R. ; M. NILSON ; SOLBERG U., Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2000FRANÇAIS : Cette monographie constitue les actes de la seconde conférence européenne "L'évaluation : un outil clef pour l'amélioration de la prévention de l'usage de drogues" qui s'est tenue à Strasbourg du 2 au 4 décembre 1999. Celle-ci avait[...]Rapport
FRANÇAIS : Ce rapport décrit les résultats de l'évaluation des mécanismes mis en place lors de l'adoption de "l'action commune relative à l'échange d'informations, à l'évaluation des risques et au contrôle des nouvelles drogues de synthèse", l[...]Chapitre
FRANÇAIS : De nombreux pays ont récemment adopté une «stratégie nationale antidrogue». Cette partie est axée sur les plans prévoyant l'évaluation de ces stratégies, qui a été menée à l'échelle européenne pour la première fois grâce aux travaux [...]Rapport
European Centre for Disease Prevention and Control ; OEDT = EMCDDA | Stockholm : ECDC (European Centre for Disease Prevention and Control) | Technical report | 2011This is the first of two technical reports that present the evidence behind the "Guidance on the prevention and control of infectious diseases among people who inject drugs". The evidence presented here focuses on the effectiveness (and in some[...]Rapport
European Centre for Disease Prevention and Control ; OEDT = EMCDDA | Stockholm : ECDC (European Centre for Disease Prevention and Control) | Technical report | 2011The aim of the literature review presented in this report was to provide evidence to inform the recommendations made by ECDC and the EMCDDA in the 2011 'Guidance on the prevention and control of infectious diseases among people who inject drugs'[...]Rapport
This short report presents a brief overview of recent evidence for the most effective approaches in the fields of drug use prevention, drug use treatment and harm reduction. It discusses the strengths and limitations of the evidence and some cha[...]Rapport
In the period 2010-2014, the South American cocaine markets have witnessed some change in comparison to previous years, particularly with respect to (a) the estimated areas under coca bush cultivation and the potential volume of cocaine hydrochl[...]Chapitre
This Selected issue looks both at drug use among socially excluded populations (prisoners, immigrants, the homeless, sex workers and vulnerable young people) and social exclusion among drug addicts.Congrès
ENGLISH : This group has started reviewing the field and links up with another EMCDDA modelling project that has started analysing heroin markets and the effects of substitution therapy. A meeting was held in Lisbon 23-24 Oct. 2000. Researcher[...]Rapport
T. FRIIS SOGAARD ; M. HOJLUND BRAEMER ; M. MULBJERG PEDERSEN | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides an analysis of current drug supply models and the related violence and exploitation of vulnerable groups in Denmark. Recent years have seen a growth in criminals' exploitation of vulnerable groups for drug-related crimes. Th[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; T. GROSHKOVA ; D. THANKI ; A. CUNNINGHAM ; M. RYCHERT | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]Rapport
P. BLANKEN ; C. CARPENTIER ; J. M. COSTES ; S. DIEMEL ; J. GAMELLA ; P. GRIFFITHS ; R. HARTNOLL ; N. HUNT ; J. MOUNTENEY ; C. MUTATAYI ; A. ALVAREZ ROLDAN ; J. SHERVAL ; R. SIMON ; L. VINGOE | Lisbon : OEDT / EMCDDA | 1999Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. CHRISTIE ; S. SOLA ; A. ALMEIDA ; R. JORGE ; J. DE MORAIS ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2018In this update from the EU Early Warning System, the EMCDDA aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency's early warning and risk-assessment activities. This report cov[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. EVANS-BROWN ; I. GIRAUDON | Lisbon : OEDT / EMCDDA | Technical reports | 2012The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9-10 October 2012. The aim of the study was to increase understanding of the availability [...]Rapport
OEDT = EMCDDA ; C. COSTA STORTI ; D. FRASQUILHO ; G. BURKHART ; M. MOREIRA | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014The economic crisis that Europe experienced in 2008 and later presented a grave challenge to public finances. Countries responded to this by undertaking fiscal consolidation. By examining public expenditure in the areas where most drug-related a[...]Congrès
First European conference on drug supply indicators (20-22 October 2010; Brussels, Belgium) | Lisbon : OEDT / EMCDDA | Conference proceedings | 2010The conference was organised around three main thematic areas: the drug market, the drug-crime nexus, and drug supply reduction. In practical terms, the conference provided an opportunity to assess the current state of the art in data availabili[...]Rapport
Rapport
This report presents the overview of the drug phenomenon in France, covering drug supply, use and public health problems, as well as drug policy and responses. The statistical data reported relate to 2016 (or most recent year) and are provided t[...]Rapport
In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment. Furanylf[...]Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017. On the ba[...]Chapitre
The influence of gender not only on patterns and levels of drug consumption in Europe but also on how responses to drug problems are planned and implemented is explored in this Selected issue. Based on a scientific analysis of the available data[...]Rapport
J. HILLEBRAND ; D. OLSZEWSKI ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2008FRANÇAIS : Une inquiétude croissante existe au sein de l'Union européenne quant aux produits chimiques utilisés dans la production de la drogue récréative GHB. Cette déclaration figure dans ce rapport publié dans le cadre de son projet E-POD qu[...]Rapport
OEDT = EMCDDA ; ONUDC / UNODC | New York : UNODC/UNODCCP | Programme mondial d'évaluation de l'abus de drogues / Global Assessment Programme on drug abuse (GAP) | 2007The number of people seeking treatment for drug problems is a leading indicator of drug use patterns and prevalence. Data collected from this group offer a valuable 'window' onto an otherwise hidden population and a means of assessing the perfor[...]Rapport
Prices are an essential element of the illicit drug market, from both a supply and demand perspective. They are an indicator of drug availability and are an important tool for understanding the workings of drug supply mechanisms. They may also b[...]Rapport
G. P. SCALIA TOMBA ; C. ROSSI ; C. TAYLOR ; D. KLEMPOVA ; L. WIESSING | Lisbon : OEDT / EMCDDA | Scientific Reports | 2008Monitoring the incidence of problem drug use - the rate at which people who will become problem users start using or injecting drugs for the first time - plays an important part in tracing new trends in Europe’s drug situation and in helping to [...]Rapport
Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of ri[...]Rapport
FRANÇAIS : L'EMCDDA cherche à promouvoir des méthodes d'évaluation scientifique dans le champ de la prévention dans le but d'améliorer la qualité des interventions. Les recommandations de ce manuel doivent permettre de comparer les différents [...]